Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Covington
US Department of Justice
Julphar
Deloitte
Express Scripts
Queensland Health
Cipla
McKesson

Generated: December 11, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR TRUVADA

« Back to Dashboard

Clinical Trials for Truvada

Trial ID Title Status Sponsor Phase Summary
NCT00074581 Preventing Sexual Transmission of HIV With Anti-HIV Drugs Completed HIV Prevention Trials Network Phase 3 This study will determine whether anti-HIV drugs can prevent the sexual transmission of HIV among couples in which one partner is HIV infected and the other is not.
NCT00074581 Preventing Sexual Transmission of HIV With Anti-HIV Drugs Completed National Institute of Allergy and Infectious Diseases (NIAID) Phase 3 This study will determine whether anti-HIV drugs can prevent the sexual transmission of HIV among couples in which one partner is HIV infected and the other is not.
NCT00090779 Nine Month Course of Anti-HIV Medications for People Recently Infected With HIV Terminated Adult AIDS Clinical Trials Group Phase 2 Although some doctors favor starting anti-HIV treatment as soon as possible after patients learn they are infected, it is not known if treatment for recently infected patients results in long-term benefits or harm. The purpose of this study is to learn whether or not people should take anti-HIV drugs when they are first infected.
NCT00090779 Nine Month Course of Anti-HIV Medications for People Recently Infected With HIV Terminated National Institute of Allergy and Infectious Diseases (NIAID) Phase 2 Although some doctors favor starting anti-HIV treatment as soon as possible after patients learn they are infected, it is not known if treatment for recently infected patients results in long-term benefits or harm. The purpose of this study is to learn whether or not people should take anti-HIV drugs when they are first infected.
NCT00090779 Nine Month Course of Anti-HIV Medications for People Recently Infected With HIV Terminated AIDS Clinical Trials Group Phase 2 Although some doctors favor starting anti-HIV treatment as soon as possible after patients learn they are infected, it is not known if treatment for recently infected patients results in long-term benefits or harm. The purpose of this study is to learn whether or not people should take anti-HIV drugs when they are first infected.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Truvada

Condition Name

Condition Name for Truvada
Intervention Trials
HIV Infections 73
HIV 48
HIV Infection 18
HIV-1 Infection 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Truvada
Intervention Trials
HIV Infections 108
Acquired Immunodeficiency Syndrome 39
Infection 27
Communicable Diseases 15
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Truvada

Trials by Country

Trials by Country for Truvada
Location Trials
United States 504
Canada 54
South Africa 41
United Kingdom 39
France 34
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Truvada
Location Trials
California 45
Florida 33
Texas 31
North Carolina 31
Massachusetts 29
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Truvada

Clinical Trial Phase

Clinical Trial Phase for Truvada
Clinical Trial Phase Trials
Phase 4 66
Phase 3 43
Phase 2/Phase 3 5
[disabled in preview] 30
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Truvada
Clinical Trial Phase Trials
Completed 116
Recruiting 23
Active, not recruiting 14
[disabled in preview] 24
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Truvada

Sponsor Name

Sponsor Name for Truvada
Sponsor Trials
Gilead Sciences 52
Merck Sharp & Dohme Corp. 32
National Institute of Allergy and Infectious Diseases (NIAID) 20
[disabled in preview] 14
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Truvada
Sponsor Trials
Other 223
Industry 134
NIH 31
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Express Scripts
Medtronic
Federal Trade Commission
Accenture
McKinsey
Fish and Richardson
Queensland Health
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.